% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 54

Loading Chart...

4 inventors (with patents filed for the assignee):

Michael P McKenna (6 out of 12 patents)

Michael S Urdea (6 out of 63 patents)

Patrick A Arensdorf (3 out of 20 patents)

4. Scott Eastman (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8409816 - Diabetes-related biomarkers and methods of use thereof (2013-04-02),

2. 8357497 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2013-01-22),

3. 8232065 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2012-07-31),

4. 8119358 - Diabetes-related biomarkers and methods of use thereof (2012-02-21),

5. 8097425 - Multiplex protein fractionation (2012-01-17),

6. 7723050 - Diabetes-related biomarkers and methods of use thereof (2010-05-25),

Company Overview

Tethys Bioscience, Inc. offers personalized medicine solutions for individuals at risk for chronic conditions such as diabetes and cardiovascular disease. With a focus on preventive healthcare, the company utilizes advanced molecular diagnostics to provide actionable insights for early intervention and treatment. Tethys Bioscience is committed to improving health outcomes and reducing healthcare costs through precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#81 in Emeryville, CA

#10,578 in California

#45,007 in US

Emeryville, CA, United States of America

Tethys Bioscience, Inc.

Forward Citations = 54

4 inventors:

Michael P McKenna (6 out of 12 patents)

Michael S Urdea (6 out of 63 patents)

Patrick A Arensdorf (3 out of 20 patents)

4. Scott Eastman (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tethys Bioscience, Inc.. Retrieved from https://idiyas.com/company/tethys-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]